AI-generated summary
The authors tested an enhanced evening light therapy against a dim light placebo in 47 older adults with advanced sleep phase syndrome over 28 days. Enhanced light was no more effective than placebo on objective sleep and melatonin measures, though participants reported subjective benefit and a significant delay in sleep onset, and the authors describe the overall benefits as statistically equivocal.
- Participants
- 47
- Who or what was studied
- Older adults aged 60 to 86 with self-reported advanced sleep phase syndrome symptoms (21 men, 26 women)
- Limits stated in the abstract
- The authors describe the benefits as statistically equivocal, and the abstract reports no significant difference from placebo on objective measures.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Lux. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.